Faculty Opinions recommendation of Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

Author(s):  
Jose Biller
The Lancet ◽  
2016 ◽  
Vol 387 (10038) ◽  
pp. 2605-2613 ◽  
Author(s):  
M Irem Baharoglu ◽  
Charlotte Cordonnier ◽  
Rustam Al-Shahi Salman ◽  
Koen de Gans ◽  
Maria M Koopman ◽  
...  

CJEM ◽  
2018 ◽  
Vol 20 (S2) ◽  
pp. S78-S81 ◽  
Author(s):  
Onyinyechi Eke ◽  
Mercedeh Shanechi ◽  
Michael Gottlieb

Clinical questionIn patients taking antiplatelet therapy, does a platelet transfusion after acute spontaneous primary intracerebral hemorrhage reduce the risk of death or dependence?Article chosenBaharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral hemorrhage associated with antiplatelet therapy (PATCH): a randomized, open-label, phase 3 trial.Lancet2016;387(10038):2605-13.Study objectiveThe primary objective of this study was to investigate whether a platelet transfusion with standard care, compared with standard care alone, reduced death or dependence after intracerebral hemorrhage associated with antiplatelet therapy use.


Sign in / Sign up

Export Citation Format

Share Document